Breast cancer treatments rely on multidisciplinary coordination, and corresponding therapies have evolved in diverse directions, including surgery, radiation, chemotherapy, immunotherapy, endocrine therapy (e.g., estrogen-receptor-directed tamoxifen) [235], HER2-directed trastuzumab [236], and biological therapy. This evidence concerns the gene ERBB2 and breast cancer.